Short answer
Definium Therapeutics, Inc. (DFTX) filed an 8-K current report with the SEC on May 7, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Fiscal quarter ended March 31, 2026 results announced on May 7, 2026.
Definium Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Fiscal quarter ended March 31, 2026 results announced on May 7, 2026
- Conference call scheduled to discuss financial results and recent corporate highlights
- Detailed results and management commentary available in Exhibit 99.1 press release
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Definium Therapeutics, Inc. 8-K filings
Get the next DFTX 8-K as it lands
Follow DFTX for push alerts, or ask the research agent what this filing means.